Journal News

Rethinking how culture medium contributes to cellular function

Isha Dey
Jan. 4, 2022

Cell culture medium, as we know, contains a combination of growth factors and other components that help researchers grow cells in the lab. An important constituent in the growth medium is serum, an animal-derived complex of growth factors, amino acids and lipids, which provides nutrition to the growing cells. Researchers lack complete information on serum composition and its lot-to-lot variability but have studied the effects of some growth medium components on cellular metabolism. However, they do not yet understand fully the impact of the medium’s lipid content on cell function.

The powerhouse of human cells is mitochondria. An important component that determines mitochondrial function is cardiolipins, or CLs. These phospholipids located on the inner mitochondrial membrane are involved in mitochondrial bioenergetics and maintaining architecture of the mitochondrial membranes as well as in scavenging reactive oxygen species. However, cardiolipin composition is different in different tissues of the body, and because CLs play a central role in mitochondrial function, this means cells in different organs have varied mitochondrial activity.

To better understand the effect of nutrition, especially lipids, on mitochondrial CL composition and function, Markus Keller’s lab at the Medical University of Innsbruck in Austria cultured mammalian cells in lipid-free medium and then fed them with various types of lipids. Using mass spectrometry lipidomics and mathematical modeling, the authors were able to quantify the CL composition in the presence of different fatty acids in the growth medium.

Specifically, addition of linoleic acid to the medium altered 76% of the natural CL side chain composition compared to untreated medium. Addition of alpha linolenic acid and arachidonic acid also altered CL side chain composition significantly. Moreover, linoleic acid treatment increased the activity of the mitochondrial respiratory complex I, which is responsible for generating ATP and thus regulates normal functioning of a cell. The lab’s breakthrough findings were published in the Journal of Lipid Research.

Gregor Oemer, the first author on the paper, said an initial challenge of this project was finding cells that would grow without lipids, which are usually necessary for cell proliferation. “We got Panserin 401 (a serum-free medium) from a German biotech company and luckily got our HeLa cells to grow in this lipid-free medium,” he said.

The work was a collaborative effort. “We were in luck because Innsbruck is the home base for Oroboros, one of the most renowned respirometry companies,” Oemer said, “and thanks to Erich Gnaiger, the head, we collaborated for the respirometry assays.”

This project was a continuation of Oemer’s master’s thesis from the Keller lab. “Lipid metabolism is very complex but quite fascinating, and we don’t know much about it,” he said.

What struck Oemer most was how, by just altering the lipid intake, the researchers were able to influence critical cellular functions. He hopes the work raises awareness that variations in serum in cell culture medium may alter experimental data. This is especially important while studying diseases such as Barth syndrome, a genetic disorder characterized by abnormalities in mitochondrial cardiolipins.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Isha Dey

Isha Dey is a scientist at Thermo Fisher Scientific.

Related articles

From the journals: JLR
Swarnali Roy
From the journals: JLR
Swarnali Roy
From the journals: JLR
Nivedita Uday Hegdekar
From the journals: JLR
Clementine Adeyemi
From the journals: JLR
Lisa Learman & Laurel Oldach

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Melissa Moore to speak at ASBMB 2025
ASBMB Annual Meeting

Melissa Moore to speak at ASBMB 2025

April 2, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.

 A new kind of stem cell is revolutionizing regenerative medicine
Feature

A new kind of stem cell is revolutionizing regenerative medicine

April 1, 2025

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell longevity and immune rejection.

Engineering the future with synthetic biology
ASBMB Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the ASBMB 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance
Webinar

Scientists find bacterial ‘Achilles’ heel’ to combat antibiotic resistance

March 28, 2025

Alejandro Vila, an ASBMB Breakthroughs speaker, discussed his work on metallo-β-lactamase enzymes and their dependence on zinc.

Host vs. pathogen and the molecular arms race
ASBMB Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the ASBMB 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

Richard Silverman to speak at ASBMB 2025
ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.